Resources for Health Care Professionals

2020-2021, Volume 2 Special Edition for Health Care Professionals

TMS proudly presents the updated 2020-2021 Volume 2 Special Edition for Health Care Professionals. The 2020-2021 Volume 2 Special Edition covers summaries on mast cell definitions, diagnosis and classification, cytology of mast cells, tests, treatments and medications as well as other topics. 

DOWNLOAD HERE


Mast Cell Disease TeleECHO

Mast Cell Disease TeleECHO is a free program for physicians who want to improve their ability to care for people with mast cell disease and associated conditions. The program consists of expert presentations and case-based interactive sessions delivered virtually via the Zoom platform. Each session is 1hr in length. All participants are encouraged to share their cases and questions in the sessions and are guided to further educational material and support. CME credits and a certificate of completion are available to physicians at no charge. Credits are awarded at 1.0 per 60 minutes of live session activity. Participants who attend at least 6 of the 8 sessions will receive the certification of completion and be part of TMS’s physician registry for ProjectECHO graduates.

For more information visit our ProjectECHO page


Clinical Research Updates Spotlight on SM

Putting a Spotlight on Systemic Mastocytosis: A Multidisciplinary Look at Early Diagnosis and Management

Systemic mastocytosis (SM) is a group of rare disorders characterized by accumulation of mast cells in internal tissues and organs, such as the liver, spleen, bone marrow, and small intestines. Patients with SM experience symptoms that include anaphylaxis, flushing, gastrointestinal issues, fatigue, and skin lesions; the lack of specific symptoms often makes diagnosis challenging, and clinicians should be aware of the array of symptoms and signs that indicate SM. More than 90% of patients with SM have a KIT D816V mutation, which, along with serum tryptase and bone marrow biopsy, is key to diagnosing SM. Management strategies for nonadvanced SM are largely symptomatic treatment, though there are targeted therapies in clinical trials. During this Clinical Research Updates™ webcast, a multidisciplinary expert panel will review the evidence and best-practice recommendations for the early diagnosis and treatment of SM, including keys to differential diagnosis, recommendations for management, and results and progress from new clinical trials. Included within this educational activity is an “Ask the Experts” chat box feature, allowing learners to submit questions that will be answered by program faculty.

View the activity here